Since primary CTLs (CD8+ T cells) responses are important in suppressing tumor growth and helper T cells (CD4+ T cells) play important roles in the regulation of adaptive immunity, they are considered critical effectors for cancer immunotherapy43. This evidence concerns the gene CD8A and neoplasm.